- Abuse, Misuse, and Addiction
[see
Boxed Warning,
Warnings and Precautions (5.1),
Drug Abuse and Dependence (9.2)
]
- Hypersensitivity Reactions
[
see Contraindications (4)]
- Hypertensive crisis with Concomitant Use of Monoamine Oxidase Inhibitors
[see
Contraindications (4),
Drug Interactions (7)]
- Risks to Patients with Serious Cardiac Disease
[see
Warnings and Precautions (5.2)]
- Increased Blood Pressure and Heart Rate
[see
Warnings and Precautions (5.3)]
- Psychiatric Adverse Reactions
[see
Warnings and Precautions (5.4)]
- Priapism
[see
Warnings and Precautions (5.5)]
- Peripheral Vasculopathy, including Raynaud’s Phenomenon
[see
Warnings and Precautions (5.6)]
- Long-term Suppression of Growth in Pediatric Patients
[see
Warnings and Precautions (5.7)]
- Acute Angle Closure Glaucoma
[see
Warnings and Precautions (5.8)]
- Increased Intraocular Pressure and Glaucoma
[see
Warnings and Precautions (5.9)]
- Motor and Verbal Tics, and Worsening of Tourette's Syndrome
[see
Warnings and Precautions (5.10)]
The following adverse reactions associated with the use of methylphenidate were identified in clinical trials, spontaneous reports, and literature. Because these reactions were reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.
Adverse Reactions Reported with Methylphenidate Hydrochloride Extended-Release Tablets
•
Infections and Infestations: nasopharyngitis
• Blood and the Lymphatic System Disorders
:leukopenia, thrombocytopenia, anemia
• Immune System Disorders: hypersensitivity reactions, including angioedema and anaphylaxis
• Metabolism and Nutrition Disorders: decreased appetite, reduced weight gain, and suppression of growth during prolonged use in pediatric patients
• Psychiatric Disorders: insomnia, anxiety, restlessness, agitation, psychosis (sometimes with visual and tactile hallucinations), depressed mood
• Nervous System Disorders: headache, dizziness, tremor, dyskinesia including choreoathetoid movements, drowsiness, convulsions, cerebrovascular disorders (including vasculitis, cerebral hemorrhages and cerebrovascular accidents), serotonin syndrome in combination with serotonergic drugs
• Eye Disorders: blurred vision, difficulties in visual accommodation
• Cardiac Disorders: tachycardia, palpitations, increased blood pressure, arrhythmias, angina pectoris
• Respiratory, Thoracic and Mediastinal Disorders: cough
• Gastrointestinal Disorders: dry mouth, nausea, vomiting, abdominal pain, dyspepsia
• Hepatobiliary Disorders: abnormal liver function, ranging from transaminase elevation to severe hepatic injury
• Skin and Subcutaneous Tissue Disorders: hyperhidrosis, pruritus, urticaria, exfoliative dermatitis, scalp hair loss, erythema multiforme rash, thrombocytopenic purpura
• Musculoskeletal and Connective Tissue Disorders: arthralgia, muscle cramps, rhabdomyolysis
• Investigations: weight loss (adult ADHD patients)
Additional Adverse Reactions Reported with Other Methylphenidate-Containing Products
The list below shows adverse reactions reported with other methylphenidate-containing products.
• Blood and Lymphatic Disorders: pancytopenia
• Immune System Disorders: hypersensitivity reactions such as auricular swelling, bullous conditions, eruptions, exanthemas
• Psychiatric Disorders: affect lability, mania, disorientation and libido changes
• Nervous System Disorders: migraine
• Eye Disorders: diplopia, mydriasis
• Cardiac Disorders: sudden cardiac death, myocardial infarction, bradycardia, extrasystole
• Vascular Disorders: peripheral coldness, Raynaud's phenomenon
• Respiratory, Thoracic and Mediastinal Disorders: pharyngolaryngeal pain, dyspnea
• Gastrointestinal Disorders: diarrhea, constipation
• Skin and Subcutaneous Tissue Disorders: angioneurotic edema, erythema, fixed drug eruption
• Musculoskeletal, Connective Tissue and bone Disorders: myalgia, muscle twitching
• Renal and Urinary Disorders: hematuria
• Reproductive System and Breast Disorders: gynecomastia
• General Disorders: fatigue, hyperpyrexia
• Urogenital Disorders: priapism